Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate Patent Expiration

Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate was first introduced by Salix Pharmaceuticals Inc in its drug Moviprep on Aug 2, 2006. Another drug containing Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate is Plenvu. 4 different companies have introduced drugs containing Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate.


Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate Patents

Given below is the list of patents protecting Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Plenvu US10016504 Compositions Sep 10, 2033 Salix
Plenvu US10918723 Colon cleansing compositions and methods of use Sep 10, 2033 Salix
Plenvu US12083179 Colon cleansing compositions and method of use Sep 10, 2033 Salix
Plenvu US8999313 Compositions Sep 10, 2033 Salix
Plenvu US9326969 Compositions Sep 10, 2033 Salix
Plenvu US9707297 Compositions Sep 10, 2033 Salix
Plenvu US9592252 Colonoscopy—preparation Aug 11, 2032 Salix
Plenvu US10646512 Colonoscopy - preparation Mar 25, 2032 Salix
Plenvu US10780112 Colonoscopy-preparation Mar 09, 2032 Salix
Plenvu US10792306 Colonoscopy—preparation Mar 09, 2032 Salix
Plenvu US11529368 Colonoscopy—preparation Mar 09, 2032 Salix
Moviprep US7169381 Colon cleansing compositions and methods Sep 01, 2024

(Expired)

 Salix Pharms
Moviprep US7658914 Colon cleansing compositions Sep 01, 2024

(Expired)

 Salix Pharms



Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate Generic API Manufacturers

Several generic applications have been filed for Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate. The first generic version for Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate was by Novel Laboratories Inc and was approved on Jan 25, 2012. And the latest generic version is by Taro Pharmaceutical Industries Ltd and was approved on Jun 28, 2024.

Given below is the list of companies who have filed for Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate generic, along with the locations of their manufacturing plants worldwide.


1. NOVEL LABS INC

Novel Laboratories Inc has filed for 1 generic for Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate. This 4.7gm;100gm;1.015gm;5.9gm;2.691gm;7.5gm version comes by the name PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4.7GM; 100GM; 1.015GM; 5.9GM; 2.691GM; 7.5GM

for solution Prescription ORAL AA Jan 25, 2012





2. TARO

Taro Pharmaceutical Industries Ltd has filed for 1 generic for Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate. This 4.7gm;100gm;1.015gm;5.9gm;2.691gm;7.5gm version comes by the name PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4.7GM; 100GM; 1.015GM; 5.9GM; 2.691GM; 7.5GM

for solution Prescription ORAL AA Jun 28, 2024


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Honolulu Taro Delight, LLC
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.